Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals

The FDA authorized new long-acting monoclonal antibodies for the pre-exposure prevention of COVID-19 in certain adults and pediatric individuals.